Nodules in PSVD - Paris PSVD Meeting

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the challenging diagnosis of liver nodules in PSVD, synthesizing current knowledge from both radiology and pathology. The argumentation is solid, grounded in clinical experience and published literature, with clear acknowledgment of the limitations and gaps in PSVD-specific data. The speakers effectively use examples and case illustrations to support their points, and they emphasize the importance of a multidisciplinary approach. The discussion of ancillary imaging features and the role of liver-specific contrast agents is particularly informative, offering practical guidance for clinicians. The pathological classification and the proposal for updated terminology are well-argued, reflecting ongoing efforts to standardize diagnosis. Overall, the value lies in its comprehensive overview and the expert perspectives shared, which are crucial for healthcare professionals managing these patients.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor, with references to published studies and ongoing research, including work by the International Liver Pathologists Study Group and a molecular characterization study in Paris. The speakers clearly distinguish between established knowledge and extrapolations from other vascular liver diseases, appropriately cautioning about the lack of PSVD-specific data. The title accurately reflects the content, focusing on nodules in PSVD as presented at a specialized meeting. The content is well-structured, and the speakers’ expertise is evident. No comments were provided, so no analysis of public feedback is included.

The title accurately reflects the content, focusing on liver nodules in PSVD as presented at a specialized meeting.

8/10

Presentation by two recognized experts in liver pathology and radiology, based on established literature and clinical experience, with clear acknowledgment of data limitations in PSVD.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Prof. Sempoux on hepatocellular nodules in vascular liver disease, highlighting the role of blood flow alterations.
• 02:00Prof. Ronot discusses imaging features of nodules in vascular liver disease, emphasizing the non-specificity of washout and the utility of liver-specific contrast agents.
• 06:00Prof. Ronot presents examples of benign and malignant nodules in Budd-Chiari syndrome and Fontan-associated liver disease, illustrating imaging patterns.
• 10:00Prof. Ronot addresses nodules in PSVD, noting the lack of dedicated imaging studies and the variable prevalence (5-30%).
• 13:00Prof. Sempoux begins the pathological perspective, describing large regenerative nodules and FNH, including their histological features.
• 16:00Prof. Sempoux discusses FNH-like nodules, their overlapping features, and the role of molecular analysis in atypical cases.
• 19:00Prof. Sempoux reviews nodules in Budd-Chiari syndrome, Fontan-associated liver disease, congenital portosystemic shunts, and HHT, highlighting frequencies and risks.
• 22:00Prof. Sempoux presents data on nodules in PSVD, including prevalence and the low incidence of HCC, with illustrative cases.
• 25:00Summary of findings across vascular liver diseases and discussion of challenges, including terminology standardization and the need for molecular studies.
• 28:00Conclusion and Q&A session, addressing biopsy sampling in PSVD and the heterogeneity of the disease.

• FILFOIE website — Mentioned in the video description as the network's official website.
• Chapter by Valerie and Aurelie Bouffard — Referenced by Prof. Sempoux as a source for histopathological images of liver nodules.

• FILFOIE website — The video description mentions this website as the official FILFOIE network site, which likely contains additional information on PSVD.